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Abstract Streptococcus dysgalactiae is a pyogenic spe-
cies pathogenic both for humans and animals. Until
recently, it has been considered an exclusive animal
pathogen causing infections in wild as well as domestic
animals. Currently, human infections are being reported
with increasing frequency, and their clinical picture is
often similar to the ones caused by Streptococcus pyo-
genes. Due to the fact that S. dysgalactiae is a heteroge-
neous species, it was divided into two subspecies: S.
dysgalactiae subsp. equisimilis (SDSE) and S. dysgalac-
tiae subsp. dysgalactiae (SDSD). The first differentiation
criterion, described in 1996, was based on strain isolation
source. Currently applied criteria, published in 1998, are
based on hemolysis type and Lancefield group classifi-
cation. In this study, we compared subspecies identifica-
tion results for 36 strains isolated from clinical cases both
in humans and animals. Species differentiation was based
on two previously described criteria as well as MALDI-
TOF and genetic analyses: RISA and 16S rRNA genes
sequencing. Antimicrobial susceptibility profiles were
also determined according to CLSI guidelines. The results
presented in our study suggest that the subspecies dif-
ferentiation criteria previously described in the above two
literature positions seem to be inaccurate in analyzed
group of strains, the hemolysis type on blood agar, and
Lancefield classification should not be here longer con-
sidered as criteria in subspecies identification. The
antimicrobial susceptibility tests indicate emerging of
multiresistant human SDSE strains resistant also to van-
comycin, linezolid and tigecycline, which might pose a
substantial problem in treatment.
Introduction
Streptococcus dysgalactiae is a pyogenic species patho-
genic both for humans and animals. Until recently, it has
been considered an exclusive animal pathogen causing
infections in wild animals, livestock, and pets. Currently,
human infections are being reported with increasing fre-
quency. Their clinical picture is often similar to the ones
caused by group A streptococcus (Streptococcus pyoge-
nes) [3].
S. dysgalactiae proved to be a heterogeneous species,
what encouraged researchers to divide it into two sub-
species: S. dysgalactiae subsp. equisimilis (SDSE) and S.
dysgalactiae subsp. dysgalactiae (SDSD). The first differ-
entiation criterion was proposed in 1996 by Vandamme
et al. [22], second criteria—only 2 years later—in 1998 by
Vieira et al. [23] which are being applied up to the present.
Over the years, controversies arose over this classification,
showing that the streptococci taxonomy has not been
completed yet and generally used S. dysgalactiae sub-
species division causes more questions than solutions. In
some research reports, subspecies names are used instead
of species (i.e., S. equisimilis), which causes unnecessary
confusion in diagnostics [4, 19].
The presented study provides a new view on S. dys-
galactiae identification, subspecies differentiation criteria
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30 human S. dysgalactiae isolates from clinical cases
(mainly wounds, abscesses, bedsores, noses, ears, throats)
were obtained from Synevo Medical Laboratory in Ło´dz´,
Poland.
6 animal S. dysgalactiae isolates from clinical cases in
pets (dogs—from wounds, abscesses, birth canal) were
obtained from VETCOMPLEX Veterinary Diagnostic
Centre in Ło´dz´, Poland.
Phenotypic Bacterial Identification According
to Vieira et al. [23]
Hemolysis type was evaluated as well as Lancefield group.
The type of hemolysis was observed after a 24-h incubation
at 37 C (aerobic atmosphere) on agar plates containing
5 % defibrinated sheep blood. The type of surface
C-polysaccharide, classifying analyzed strains to serologi-
cal groups according to Lancefield, was evaluated using
latex agglutination tests with Prolex Streptococcal Group-
ing Latex Kit.
Bacterial Identification Based on Cell Proteins
Structure and DNA Sequences
MALDI-TOF technique (matrix-assisted laser desorption
ionization-time of flight) [5] which compares cell proteins
specters with database (bioMe´rieux VITEK MS) was
employed to identify the analyzed clinical strains.
All bacterial strains were also identified by means of
RISA (16S–23S rDNA intergenic spacer region) method.
PCR reactions were conducted using S. dysgalactiae spe-
cies-specific primers (Fwd 50-TGGAACACGTTAGGG
TCG-30, Rev 50-CTTAACTAGAAAAACTCTTGATTA
TTC-30) [9] and SDSE subspecies-specific primers (Fwd
50-GGTACTGTTGAGGGGACGAA-30, Rev 50-CGATT
GAGGAGTCACGTTCA-30) [16].
Genetic identification of the selected strains was also
confirmed by means of amplification of 16S rRNA coding
genes from the selected strains, using primers described in
the paper (8F 50-GAGAGTTTGATCCTGGCTCAG-30,
1942R 50-TACGGCTACCTTGTTACGACT-30) [21].
Afterward, amplified DNA fragments were sequenced and
compared with Genbank database. The obtained sequences
were published in Genbank.
Antimicrobial Susceptibility
The antibiotic susceptibility tests of the analyzed strains
were performed by means of disk diffusion method
according to Clinical & Laboratory Standards Institute
(CLSI) [6] and Polish National Reference Centre for
Antibiotics (KORLD) [26] guidelines. Susceptibility to 10
antibiotics, representative of the main antibiotic classes and
recommended for streptococcal infections treatment, were
determined: penicillin (10 U), erythromycin (15 lg), clin-
damycin (2 lg), ofloxacin (5 lg), levofloxacin (5 lg),
vancomycin (30 lg), tetracycline (30 lg), tigecycline
(15 lg), linezolid (30 lg), and cefotaxime (30 lg). The
results were interpreted according to CLSI recommenda-
tions [6].
Results
Our findings refer to the strains collected over the period of
2014 in the area of Ło´dz´. They were more frequently
isolated from purulent infections in humans than in
animals.
The analyzed S. dysgalactiae strains were assigned to
subspecies according to the criteria proposed by Van-
damme et al., Vieira et al., as well as to the results of
MALDI-TOF method and genetic studies (Table 1). The
classification by Vandamme et al. was based on strain
isolation sources. 30 human isolates were classified as
SDSE, whereas 6 animal isolates were classified as SDSD
subspecies.
Subspecies identification according to Vieira et al. was
based on phenotypic characteristics: hemolysis type and
Lancefield group. Among 30 human S. dysgalactiae iso-
lates, nine (30 %) demonstrated a-type hemolysis, whereas
21 (70 %) demonstrated b-type hemolysis on blood agar.
Among animal isolates, one (17 %) showed a-type
hemolysis, whereas other five (83 %) showed b-type
hemolysis on blood agar. Both human and animal isolates
were classified to Lancefield groups C or G. 16 (53 %)
human isolates belonged to group C, 14 (47 %) to group G.
Among animal isolates, 1 (17 %) was classified to group C,
whereas other 5 (83 %) to Lancefield group G. According
to subspecies division criteria proposed by Vieira et al.,
among human isolates, 21 (70 %) might be classified to
SDSE, 5 (17 %) to SDSD, but 4 isolates (13 %) did not
match the criteria for neither of the subspecies. 5 (83 %)
animal isolates might be classified to SDSE, whereas 1
(17 %) did not match the criteria for neither of the sub-
species according to Vieira et al.
All analyzed strains were unequivocally identified as
SDSE by means of MALDI-TOF technique and RISA
genetic method. Additionally, sequencing of the genes
coding for 16S rRNA, isolated from seven strains
exhibiting various phenotypic characteristics (Table 1,
bolded strains) confirmed their phylogenetic affiliation to
SDSE subspecies. All obtained sequences showed over
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99 % similarity to SDSE sequences previously deposited in
Genbank. Sequences of genes coding for 16S rRNA
obtained from six human isolates were also deposited in
Genbank under accession numbers KR092084, KR559932,
KR559933, KR559934, KR559935, and KR559936,
whereas one from animal strain isolated from a dog was
deposited in KT232322.
Antimicrobial Susceptibility
Antibiotic susceptibility profiles of human and animal
isolates were roughly similar. The analyzed strains were
generally susceptible to b-lactams; however, two human
isolates were resistant to penicillin while one animal isolate
was resistant to cefotaxime. Moreover, a substantial num-
ber of them were resistant to tetracycline, clindamycin, and
erythromycin. Three strains showed induced-type MLSB
multiresistance (one animal and two human isolates).
Among the strains isolated from humans, three were
resistant both to vancomycin and linezolid, whereas other
three were resistant to tigecycline. Detailed antimicrobial
susceptibility results are presented in Table 2.
Discussion
The first attempt to delineate the division criteria between
S. dysgalactiae subspecies were undertaken by Vandamme
et al. [22] in 1996. They were based on strain isolation
source. According to this criterion, Lancefield C or G
human isolates were classified to SDSE, whereas all strains
isolated from animals were classified to SDSD. This clas-
sification reflected neither phenotypic nor genetic diversity
of S. dysgalactiae species. Only 2 years later, in 1998, the
division criteria were updated by Vieira et al. [23].
According to them, b-hemolytic Lancefield group C, G, or
L strains were classified to SDSE, whereas nonhemolytic
or a-hemolytic Lancefield group C strains were classified
to SDSD. The latter division criteria have been used up to
the present. However, many exceptions to these rules
appear in literature, e.g., SDSE strains with Lancefield
group A surface antigens [2, 20]. Moreover, not every
SDSE strain is b-hemolytic on sheep blood agar [7].
Because of these ambiguities, some researchers continue to
take into account the source of isolation as a division cri-
terion. Therefore, animal infections are being assigned to
SDSD strains, whereas human infections are being
assigned to SDSE. Despite the fact that the etiological
factor of the majority of human infections reported in lit-
erature is SDSE [17, 21] and of animal infections—SDSD
[1, 10, 18], some cases contradicting this rule were repor-
ted, e.g., human infections caused by SDSD [14] and ani-
mal infections caused by SDSE [15].
The results of identification of the group of 36 isolates
presented in this study question the subspecies division
criteria described both by Vandamme et al. [22] and by
Vieira et al. [23].
The conducted research suggests that the S. dysgalactiae
hemolysis type on blood agar should not be longer con-
sidered a criterion in subspecies differentiation, at least in
analyzed group of strains. Despite the fact that classifica-
tion to Lancefield groups (C or G) confirms the SDSE
characterization described by Vieira et al. [23], it is not an
explicit and sufficient criterion. The same C-polysaccha-
ride type (Lancefield group C) is also described as a feature
of SDSD strains.
The presented results demonstrate that S. dysgalactiae
strains isolated from clinical cases in animals might be
Table 1 The comparison of S. dysgalactiae subspecies identification results according to various criteria













Human S. dysgalactiae isolates
SV106, SV260, SV376, SV430, SV468,
SV469, SV515, SV543, SV598,
SV650, SV668
b C SDSE SDSE SDSE
SV159, SV296, SV464, SV475, SV540,
SV588, SV634, SV652, SV662,
SV773
b G SDSE SDSE SDSE
SV204, SV252, SV279, SV282, SV301 a C SDSE SDSD SDSE
SV202, SV213, SV387, SV631 a G SDSE —– SDSE
Animal S. dysgalactiae isolates
Z2 b C SDSD SDSE SDSE
K1, K2, K3, Z6 b G SDSD SDSE SDSE
Z1 a G SDSD —– SDSE
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identified as SDSE by means of currently available meth-
ods and their identification according to previously
described criteria seems to be questionable.
Currently used S. dysgalactiae subspecies division cri-
teria, described by Vieira et al., were established in the
1990s, so nearly 20 years ago. Therefore, currently avail-
able techniques allowing to analyze the relationship
between strains much more precisely should be introduced.
There is a possibility that in described period such changes
in strains within S. dysgalactiae species occurred which
obscure the differences between subspecies noted previ-
ously. Such a phenomenon is particularly apparent in
bacteria which cross the animal-to-human interspecies
barrier. The outline of evolutionary changes during this
process was presented in 2007 in Nature by Wolfe et al.
[25]. An adaptation to a new host is divided into several
stages which sometimes might last unexpectedly short.
One of the elements of this process, which has been
already proven for other streptococci species [12], is hor-
izontal gene transfer (HGT) from related species already
adapted to human host. Horizontal gene transfer between S.
pyogenes and S. dysgalactiae [8, 13] has already been
recorded. It might lead to the emergence of a new, dan-
gerous pathogen for human with the ability to be trans-
ferred via companion animals. We believe that presented
results from relatively small group of strains should initiate
the discussion about subspecies division criteria re-
evaluation.
Antimicrobial susceptibility profiles of human and ani-
mal SDSE isolates presented in this study show that mul-
tiresistant strains emerge among human isolates. Some of
them are also resistant to relatively new antibiotics which
additionally enhance the threat.
Due to an increasing genetic variability and phenotypic
variability of S. dysgalactiae strains isolated both from
humans and animals as a result, the division into sub-
species established many years ago seems to be question-
able, especially when the division criteria are so
underspecified. At this moment also, reflections about pan-
genome and the general problem of bacterial species def-
inition [11] might be taken into consideration. Although, if
the division into two subspecies remains, which in the light
of the presented data might be clinically negligible, the
division into subspecies should base also on genetic anal-
yses by means of DNA sequences unique for the sub-
species (DNA fingerprint), including RISA method
presented in this study as well as 16S rRNA genes
sequencing. The latter method is also the basis for a phy-
logenetic relationship tree published in the latest issue of
Bergey’s manual of systematic bacteriology [24].
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